Phenomenology and treatment of tremor disorders. Neurologic Clin 2001;19:3:651-680.
Zesiewicz, TA, and RA Hauser. 2001. “Phenomenology and Treatment of Tremor Disorders. Neurologic Clin 2001;19:3:651-680.”. Neurologic Clin.
Search
Search results
356 results found
Diffuse Lewy Body Disease. Current Treatment Options in Neurology 2001;6:507-518.
Zesiewicz, TA, MJ Baker, PB Dunne, and RA Hauser. 2001. “Diffuse Lewy Body Disease. Current Treatment Options in Neurology 2001;6:507-518.”. Current Treatment Options in Neurology.
Neural transplantation in Parkinson’s disease. Advances in Neurology 2001;86:435-445.
Freeman, TB, A Willing, T Zigova, PR Sanberg, and RA Hauser. 2001. “Neural Transplantation in Parkinson’s Disease. Advances in Neurology 2001;86:435-445.”. Advances in Neurology.
Modafinil treatment of pramipexole-associated somnolence. Mov Disord 2000;15:1269-1271.
Hauser, RA, MN Wahba, TA Zesiewicz, , and W Anderson. 2000. “Modafinil Treatment of Pramipexole-Associated Somnolence. Mov Disord 2000;15:1269-1271.”. Mov Disord.
Delayed stimulation-induced thalamic ataxia syndrome. Neurology 1998:50:1184-1185.
Hauser, RA, J Friedlander, DA Smith, and MF Nolan. 1998. “Delayed Stimulation-Induced Thalamic Ataxia Syndrome. Neurology 1998:50:1184-1185.”. Neurology.
A pilot evaluation of the tolerability, safety and efficacy of tolcapone alone, and in combination with oral selegiline, in untreated Parkinson’s disease patients. Movement Disorders 1998;13:643-647.
Hauser, RA, E Molho, H Shale, S Pedder, EE Dorflinger, and Tolcapone De Novo Study Group. 1998. “A Pilot Evaluation of the Tolerability, Safety and Efficacy of Tolcapone Alone, and in Combination With Oral Selegiline, in Untreated Parkinson’s Disease Patients. Movement Disorders 1998;13:643-647.”. Movement Disorders.